RUNNING POINT CAPITAL ADVISORS, LLC Karyopharm Therapeutics Inc. Transaction History

RUNNING POINT CAPITAL ADVISORS, LLC portfolio value:

$55,000
portfolio value

RUNNING POINT CAPITAL ADVISORS, LLC quarter portfolio value change:

+21.06%
quarter

Karyopharm Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 10K $5.46 10K
Q2 2022 share 0.00% 0 shares -29K $4.51 10K
Q1 2022 share Increase 0.00% 10K shares 74K $7.37 10K